Table 1.

The mean (± standard deviation) age and number of ranibizumab injections in each treatment schedule group

Treatment schedule		No. injections
During the third year	Age	During the first year including three monthly injections	During the second year	During the third year
All eyes (n = 128)	73 (8)	4.2 (1.3)	2.2 (1.9)	3.9 (4.1)
As-needed- injections determined by quarterly examination schedule
(n = 28)	73 (8)	4.3 (1.6)	0.6 (0.9)	1.0 (0.9)
As-needed injections determined by monthly examinations schedule
(n = 61)	71 (8)	4.0 (1.2)	1.5 (0.9)	1.8 (1.1)
Monthly injection schedule (n = 18)	75 (8)	4.3 (1.8)	5.5 (0.8)	11.4 (0.7)
Treat-and-extend schedule (n = 21)	78 (7)	4.6 (1.0)	3.8 (0.6)	6.4 (2.4)